Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for egfrviii (compound)
Most Correlated Studies
- Glioblastoma U87-EGFRvIII cells with RICTOR siRNA knockdown
- Glioblastoma U-87 MG cells overexpressing EGFRvIII mutation
- Glioblastoma LN229 cells overexpressing EGFRvIII in the presence or absence of TRIM24 shRNA
- Glibolastoma multiforme tissues harboring EGFR amplification and EGFRvIII mutation
- Glioblastoma U87MG cell line overexpressing constitutively phosphorylated EGFRvIII mutant
Most Relevant Literature
- In Vivo Evaluation of 68Ga-Labeled NOTA-EGFRvIII Aptamer in EGFRvIII-Positive Glioblastoma Xenograft…
- Immunohistochemical detection of EGFRvIII in glioblastoma - Anti-EGFRvIII antibody validation for di…
- EGFRvIII Confers Sensitivity to Saracatinib in a STAT5-Dependent Manner in Glioblastoma.
- The EGFRvIII transcriptome in glioblastoma: A meta-omics analysis.
- EGFR and EGFRvIII coopt host defense pathways, promoting progression in glioblastoma.
Most Relevant Clinical Trials
- Autologous T Cells Redirected to EGFRVIII-With a Chimeric Antigen Receptor in Patients With EGFRVIII…
- CAR T Cell Receptor Immunotherapy Targeting EGFRvIII for Patients With Malignant Gliomas Expressing …
- EGFRvIII CAR T Cells for Newly-Diagnosed WHO Grade IV Malignant Glioma
- A Study to Evaluate the Safety, Tolerance and Initial Efficacy of EGFRvIII CAR-T on Glioblastoma
- Pilot Study of Autologous Anti-EGFRvIII CAR T Cells in Recurrent Glioblastoma Multiforme
